Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 160
Filter
1.
Cell Rep ; 32(3): 107941, 2020 07 21.
Article in English | MEDLINE | ID: mdl-32697988

ABSTRACT

By studying healthy women who do not request analgesia during their first delivery, we investigate genetic effects on labor pain. Such women have normal sensory and psychometric test results, except for significantly higher cuff pressure pain. We find an excess of heterozygotes carrying the rare allele of SNP rs140124801 in KCNG4. The rare variant KV6.4-Met419 has a dominant-negative effect and cannot modulate the voltage dependence of KV2.1 inactivation because it fails to traffic to the plasma membrane. In vivo, Kcng4 (KV6.4) expression occurs in 40% of retrograde-labeled mouse uterine sensory neurons, all of which express KV2.1, and over 90% express the nociceptor genes Trpv1 and Scn10a. In neurons overexpressing KV6.4-Met419, the voltage dependence of inactivation for KV2.1 is more depolarized compared with neurons overexpressing KV6.4. Finally, KV6.4-Met419-overexpressing neurons have a higher action potential threshold. We conclude that KV6.4 can influence human labor pain by modulating the excitability of uterine nociceptors.


Subject(s)
Labor Pain/metabolism , Potassium Channels, Voltage-Gated/metabolism , Protein Subunits/metabolism , Adult , Alleles , Amino Acid Sequence , Analgesics/pharmacology , Animals , Base Sequence , Cell Membrane/metabolism , Cognition , Cohort Studies , Emotions , Female , Ganglia, Spinal/metabolism , Heterozygote , Humans , Ion Channel Gating/genetics , Labor Pain/genetics , Labor Pain/physiopathology , Male , Mice, Inbred C57BL , Models, Biological , Mutation/genetics , Nociceptors/metabolism , Pain Threshold , Polymorphism, Single Nucleotide/genetics , Potassium Channels, Voltage-Gated/chemistry , Potassium Channels, Voltage-Gated/genetics , Pregnancy , Protein Multimerization , Sensory Receptor Cells/metabolism , Shab Potassium Channels/metabolism , Subcellular Fractions/metabolism , Uterus/innervation
2.
Biochem Pharmacol ; 174: 113834, 2020 04.
Article in English | MEDLINE | ID: mdl-32027884

ABSTRACT

Acid-sensing ion channels (ASICs) are voltage-independent cation channels that detect decreases in extracellular pH. Dysregulation of ASICs underpins a number of pathologies. Of particular interest is ASIC3, which is recognised as a key sensor of acid-induced pain and is important in the establishment of pain arising from inflammatory conditions, such as rheumatoid arthritis. Thus, the identification of new ASIC3 modulators and the mechanistic understanding of how these compounds modulate ASIC3 could be important for the development of new strategies to counteract the detrimental effects of dysregulated ASIC3 activity in inflammation. Here, we report the identification of novel ASIC3 modulators based on the ASIC3 agonist, 2-guanidine-4-methylquinazoline (GMQ). Through a GMQ-guided in silico screening of Food and Drug administration (FDA)-approved drugs, 5 compounds were selected and tested for their modulation of rat ASIC3 (rASIC3) using whole-cell patch-clamp electrophysiology. Of the chosen drugs, guanabenz (GBZ), an α2-adrenoceptor agonist, produced similar effects to GMQ on rASIC3, activating the channel at physiological pH (pH 7.4) and potentiating its response to mild acidic (pH 7) stimuli. Sephin1, a GBZ derivative that lacks α2-adrenoceptor activity, has been proposed to act as a selective inhibitor of a regulatory subunit of the stress-induced protein phosphatase 1 (PPP1R15A) with promising therapeutic potential for the treatment of multiple sclerosis. However, we found that like GBZ, sephin1 activates rASIC3 at pH 7.4 and potentiates its response to acidic stimulation (pH 7), i.e. sephin1 is a novel modulator of rASIC3. Furthermore, docking experiments showed that, like GMQ, GBZ and sephin1 likely interact with the nonproton ligand sensor domain of rASIC3. Overall, these data demonstrate the utility of computational analysis for identifying novel ASIC3 modulators, which can be validated with electrophysiological analysis and may lead to the development of better compounds for targeting ASIC3 in the treatment of inflammatory conditions.


Subject(s)
Acid Sensing Ion Channels/metabolism , Computer Simulation , Guanabenz/analogs & derivatives , Guanabenz/metabolism , Guanidines/metabolism , Quinazolines/metabolism , Acid Sensing Ion Channels/chemistry , Allosteric Regulation/drug effects , Allosteric Regulation/physiology , Animals , CHO Cells , Cricetinae , Cricetulus , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical/methods , Guanabenz/chemistry , Guanabenz/pharmacology , Guanidines/chemistry , Guanidines/pharmacology , Protein Structure, Secondary , Quinazolines/chemistry , Quinazolines/pharmacology
3.
Physiol Rep ; 8(2): e14326, 2020 01.
Article in English | MEDLINE | ID: mdl-31960596

ABSTRACT

Galanin is a neuropeptide expressed by sensory neurones innervating the gastrointestinal (GI) tract. Galanin displays inhibitory effects on vagal afferent signaling within the upper GI tract, and the goal of this study was to determine the actions of galanin on colonic spinal afferent function. Specifically, we sought to evaluate the effect of galanin on lumbar splanchnic nerve (LSN) mechanosensitivity to noxious distending pressures and the development of hypersensitivity in the presence of inflammatory stimuli and colitis. Using ex vivo electrophysiological recordings we show that galanin produces a dose-dependent suppression of colonic LSN responses to mechanical stimuli and prevents the development of hypersensitivity to acutely administered inflammatory mediators. Using galanin receptor (GalR) agonists, we show that GalR1 activation, but not GalR2/3 activation, suppresses mechanosensitivity. The effect of galanin on colonic afferent activity was not observed in tissue from mice with dextran sodium sulfate-induced colitis. We conclude that galanin has a marked suppressive effect on colonic mechanosensitivity at noxious distending pressures and prevents the acute development of mechanical hypersensitivity to inflammatory mediators, an effect not seen in the inflamed colon. These actions highlight a potential role for galanin in the regulation of mechanical nociception in the bowel and the therapeutic potential of targeting galaninergic signaling to treat visceral hypersensitivity.


Subject(s)
Galanin/drug effects , Neurons, Afferent/physiology , Splanchnic Nerves/drug effects , Visceral Pain/physiopathology , Animals , Colon/innervation , Female , Male , Mice , Mice, Inbred C57BL , Neurons, Afferent/drug effects , Nociception , Receptors, Galanin/agonists , Splanchnic Nerves/physiology , Stress, Mechanical
4.
Pain ; 161(4): 773-786, 2020 04.
Article in English | MEDLINE | ID: mdl-31790010

ABSTRACT

The ability to sense visceral pain during appendicitis is diminished with age leading to delay in seeking health care and poorer clinical outcomes. To understand the mechanistic basis of this phenomenon, we examined visceral nociception in aged mouse and human tissue. Inflamed and noninflamed appendixes were collected from consenting patients undergoing surgery for the treatment of appendicitis or bowel cancer. Supernatants were generated by incubating samples in buffer and used to stimulate multiunit activity in intestinal preparations, or single-unit activity from teased fibres in colonic preparations, of young and old mice. Changes in afferent innervation with age were determined by measuring the density of calcitonin gene-related peptide-positive afferent fibres and by counting dorsal root ganglia back-labelled by injection of tracer dye into the wall of the colon. Finally, the effect of age on nociceptor function was studied in mouse and human colon. Afferent responses to appendicitis supernatants were greatly impaired in old mice. Further investigation revealed this was due to a marked reduction in the afferent innervation of the bowel and a substantial impairment in the ability of the remaining afferent fibres to transduce noxious stimuli. Translational studies in human tissue demonstrated a significant reduction in the multiunit but not the single-unit colonic mesenteric nerve response to capsaicin with age, indicative of a loss of nociceptor innervation. Our data demonstrate that anatomical and functional deficits in nociception occur with age, underpinning the atypical or silent presentation of appendicitis in the elderly.


Subject(s)
Appendicitis , Aged , Animals , Appendicitis/complications , Colon , Ganglia, Spinal , Humans , Mice , Neurons, Afferent , Nociception , Nociceptors , Visceral Pain
5.
Gut ; 68(4): 633-644, 2019 04.
Article in English | MEDLINE | ID: mdl-29483303

ABSTRACT

OBJECTIVE: Integration of nutritional, microbial and inflammatory events along the gut-brain axis can alter bowel physiology and organism behaviour. Colonic sensory neurons activate reflex pathways and give rise to conscious sensation, but the diversity and division of function within these neurons is poorly understood. The identification of signalling pathways contributing to visceral sensation is constrained by a paucity of molecular markers. Here we address this by comprehensive transcriptomic profiling and unsupervised clustering of individual mouse colonic sensory neurons. DESIGN: Unbiased single-cell RNA-sequencing was performed on retrogradely traced mouse colonic sensory neurons isolated from both thoracolumbar (TL) and lumbosacral (LS) dorsal root ganglia associated with lumbar splanchnic and pelvic spinal pathways, respectively. Identified neuronal subtypes were validated by single-cell qRT-PCR, immunohistochemistry (IHC) and Ca2+-imaging. RESULTS: Transcriptomic profiling and unsupervised clustering of 314 colonic sensory neurons revealed seven neuronal subtypes. Of these, five neuronal subtypes accounted for 99% of TL neurons, with LS neurons almost exclusively populating the remaining two subtypes. We identify and classify neurons based on novel subtype-specific marker genes using single-cell qRT-PCR and IHC to validate subtypes derived from RNA-sequencing. Lastly, functional Ca2+-imaging was conducted on colonic sensory neurons to demonstrate subtype-selective differential agonist activation. CONCLUSIONS: We identify seven subtypes of colonic sensory neurons using unbiased single-cell RNA-sequencing and confirm translation of patterning to protein expression, describing sensory diversity encompassing all modalities of colonic neuronal sensitivity. These results provide a pathway to molecular interrogation of colonic sensory innervation in health and disease, together with identifying novel targets for drug development.


Subject(s)
Colon/innervation , Sensory Receptor Cells/classification , Sequence Analysis, RNA , Transcriptome , Animals , Immunohistochemistry , Mice , Real-Time Polymerase Chain Reaction
6.
Sci Rep ; 9(1): 20353, 2019 12 30.
Article in English | MEDLINE | ID: mdl-31889137

ABSTRACT

In many research areas scientists are interested in clustering objects within small datasets while making use of prior knowledge from large reference datasets. We propose a method to apply the machine learning concept of transfer learning to unsupervised clustering problems and show its effectiveness in the field of single-cell RNA sequencing (scRNA-Seq). The goal of scRNA-Seq experiments is often the definition and cataloguing of cell types from the transcriptional output of individual cells. To improve the clustering of small disease- or tissue-specific datasets, for which the identification of rare cell types is often problematic, we propose a transfer learning method to utilize large and well-annotated reference datasets, such as those produced by the Human Cell Atlas. Our approach modifies the dataset of interest while incorporating key information from the larger reference dataset via Non-negative Matrix Factorization (NMF). The modified dataset is subsequently provided to a clustering algorithm. We empirically evaluate the benefits of our approach on simulated scRNA-Seq data as well as on publicly available datasets. Finally, we present results for the analysis of a recently published small dataset and find improved clustering when transferring knowledge from a large reference dataset. Implementations of the method are available at https://github.com/nicococo/scRNA.


Subject(s)
Cluster Analysis , Computational Biology , Gene Expression Profiling , Machine Learning , Sequence Analysis, RNA , Single-Cell Analysis , Algorithms , Computational Biology/methods , Gene Expression Profiling/methods , High-Throughput Nucleotide Sequencing , Humans , ROC Curve , Reproducibility of Results , Sequence Analysis, RNA/methods , Single-Cell Analysis/methods , Transcriptome
7.
Sci Signal ; 11(561)2018 12 18.
Article in English | MEDLINE | ID: mdl-30563864

ABSTRACT

Irritable bowel syndrome (IBS) is a common gastrointestinal disorder that is characterized by chronic abdominal pain concurrent with altered bowel habit. Polyunsaturated fatty acid (PUFA) metabolites are increased in abundance in IBS and are implicated in the alteration of sensation to mechanical stimuli, which is defined as visceral hypersensitivity. We sought to quantify PUFA metabolites in patients with IBS and evaluate their role in pain. Quantification of PUFA metabolites by mass spectrometry in colonic biopsies showed an increased abundance of 5-oxoeicosatetraenoic acid (5-oxoETE) only in biopsies taken from patients with IBS with predominant constipation (IBS-C). Local administration of 5-oxoETE to mice induced somatic and visceral hypersensitivity to mechanical stimuli without causing tissue inflammation. We found that 5-oxoETE directly acted on both human and mouse sensory neurons as shown by lumbar splanchnic nerve recordings and Ca2+ imaging of dorsal root ganglion (DRG) neurons. We showed that 5-oxoETE selectively stimulated nonpeptidergic, isolectin B4 (IB4)-positive DRG neurons through a phospholipase C (PLC)- and pertussis toxin-dependent mechanism, suggesting that the effect was mediated by a G protein-coupled receptor (GPCR). The MAS-related GPCR D (Mrgprd) was found in mouse colonic DRG afferents and was identified as being implicated in the noxious effects of 5-oxoETE. Together, these data suggest that 5-oxoETE, a potential biomarker of IBS-C, induces somatic and visceral hyperalgesia without inflammation in an Mrgprd-dependent manner. Thus, 5-oxoETE may play a pivotal role in the abdominal pain associated with IBS-C.


Subject(s)
Arachidonic Acids/metabolism , Irritable Bowel Syndrome/pathology , Nociception , Receptors, G-Protein-Coupled/physiology , Sensory Receptor Cells/pathology , Animals , Calcium/metabolism , Case-Control Studies , Colon/drug effects , Colon/metabolism , Colon/pathology , Constipation/chemically induced , Constipation/physiopathology , Ganglia, Spinal/drug effects , Ganglia, Spinal/metabolism , Ganglia, Spinal/pathology , Humans , Irritable Bowel Syndrome/etiology , Irritable Bowel Syndrome/metabolism , Male , Mice , Mice, Inbred C57BL , Sensory Receptor Cells/drug effects , Sensory Receptor Cells/metabolism , Signal Transduction
8.
Neuropharmacology ; 143: 49-62, 2018 12.
Article in English | MEDLINE | ID: mdl-30240782

ABSTRACT

Ongoing, spontaneous pain is characteristic of inflammatory joint pain and reduces an individual's quality of life. To understand the neural basis of inflammatory joint pain, we made a unilateral knee injection of complete Freund's adjuvant (CFA) in mice, which reduced their natural digging behavior. We hypothesized that sensitization of knee-innervating dorsal root ganglion (DRG) neurons underlies this altered behavior. To test this hypothesis, we performed electrophysiological recordings on retrograde labeled knee-innervating primary DRG neuron cultures and measured their responses to a number of electrical and chemical stimuli. We found that 24-h after CFA-induced knee inflammation, knee neurons show a decreased action potential generation threshold, as well as increased GABA and capsaicin sensitivity, but have unaltered acid sensitivity. The inflammation-induced sensitization of knee neurons persisted for 24-h in culture, but was not observed after 48-h in culture. Through immunohistochemistry, we showed that the increased knee neuron capsaicin sensitivity correlated with enhanced expression of the capsaicin receptor, transient receptor potential vanilloid 1 (TRPV1) in knee-innervating neurons of the CFA-injected side. We also observed an increase in the co-expression of TRPV1 with tropomyosin receptor kinase A (TrkA), which is the receptor for nerve growth factor (NGF), suggesting that NGF partially induces the increased TRPV1 expression. Lastly, we found that systemic administration of the TRPV1 antagonist, A-425619, reversed the decrease in digging behavior induced by CFA injection, further confirming the role of TRPV1, expressed by knee neurons, in acute inflammatory joint pain.


Subject(s)
Arthralgia/metabolism , Ganglia, Spinal/metabolism , Inflammation/metabolism , Motor Activity/physiology , Sensory Receptor Cells/metabolism , TRPV Cation Channels/metabolism , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Arthralgia/drug therapy , Arthralgia/pathology , Capsaicin , Cells, Cultured , Disease Models, Animal , Female , Freund's Adjuvant , Ganglia, Spinal/drug effects , Ganglia, Spinal/pathology , Hindlimb , Inflammation/drug therapy , Inflammation/pathology , Isoquinolines/pharmacology , Mice, Inbred C57BL , Motor Activity/drug effects , Receptor, trkA/metabolism , Sensory Receptor Cells/drug effects , TRPV Cation Channels/antagonists & inhibitors , Urea/analogs & derivatives , Urea/pharmacology , gamma-Aminobutyric Acid/metabolism
9.
Am J Physiol Gastrointest Liver Physiol ; 315(4): G464-G472, 2018 10 01.
Article in English | MEDLINE | ID: mdl-29848022

ABSTRACT

Peripheral sensitization of nociceptors during disease has long been recognized as a leading cause of inflammatory pain. However, a growing body of data generated over the last decade has led to the increased understanding that peripheral sensitization is also an important mechanism driving abdominal pain in highly prevalent functional bowel disorders, in particular, irritable bowel syndrome (IBS). As such, the development of drugs that target pain-sensing nerves innervating the bowel has the potential to be a successful analgesic strategy for the treatment of abdominal pain in both organic and functional gastrointestinal diseases. Despite the success of recent peripherally restricted approaches for the treatment of IBS, not all drugs that have shown efficacy in animal models of visceral pain have reduced pain end points in clinical trials of IBS patients, suggesting innate differences in the mechanisms of pain processing between rodents and humans and, in particular, how we model disease states. To address this gap in our understanding of peripheral nociception from the viscera and the body in general, several groups have developed experimental systems to study nociception in isolated human tissue and neurons, the findings of which we discuss in this review. Studies of human tissue identify a repertoire of human primary afferent subtypes comparable to rodent models including a nociceptor population, the targeting of which will shape future analgesic development efforts. Detailed mechanistic studies in human sensory neurons combined with unbiased RNA-sequencing approaches have revealed fundamental differences in not only receptor/channel expression but also peripheral pain pathways.


Subject(s)
Intestines/physiology , Irritable Bowel Syndrome/physiopathology , Nociception , Translational Research, Biomedical/methods , Animals , Ganglia, Spinal/physiology , Ganglia, Spinal/physiopathology , Humans , Intestines/physiopathology , Irritable Bowel Syndrome/therapy , Nociceptors/physiology
10.
Gut ; 67(1): 86-96, 2018 01.
Article in English | MEDLINE | ID: mdl-27654583

ABSTRACT

OBJECTIVE: The development of effective visceral analgesics free of deleterious gut-specific side effects is a priority. We aimed to develop a reproducible methodology to study visceral nociception in human tissue that could aid future target identification and drug evaluation. DESIGN: Electrophysiological (single unit) responses of visceral afferents to mechanical (von Frey hair (VFH) and stretch) and chemical (bradykinin and ATP) stimuli were examined. Thus, serosal afferents (putative nociceptors) were used to investigate the effect of tegaserod, and transient receptor potential channel, vanilloid 4 (TRPV4) modulation on mechanical responses. RESULTS: Two distinct afferent fibre populations, serosal (n=23) and muscular (n=21), were distinguished based on their differences in sensitivity to VFH probing and tissue stretch. Serosal units displayed sensitivity to key algesic mediators, bradykinin (6/14 units tested) and ATP (4/10), consistent with a role as polymodal nociceptors, while muscular afferents are largely insensitive to bradykinin (0/11) and ATP (1/10). Serosal nociceptor mechanosensitivity was attenuated by tegaserod (-20.8±6.9%, n=6, p<0.05), a treatment for IBS, or application of HC067047 (-34.9±10.0%, n=7, p<0.05), a TRPV4 antagonist, highlighting the utility of the preparation to examine the mechanistic action of existing drugs or novel analgesics. Repeated application of bradykinin or ATP produced consistent afferent responses following desensitisation to the first application, demonstrating their utility as test stimuli to evaluate analgesic activity. CONCLUSIONS: Functionally distinct subpopulations of human visceral afferents can be demonstrated and could provide a platform technology to further study nociception in human tissue.


Subject(s)
Gastrointestinal Agents/pharmacology , Intestines/innervation , Nociceptors/drug effects , Adenosine Triphosphate/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Bradykinin/analogs & derivatives , Bradykinin/pharmacology , Bradykinin Receptor Antagonists/pharmacology , Drug Evaluation, Preclinical/methods , Humans , Indoles/pharmacology , Intestines/drug effects , Morpholines/pharmacology , Nociceptors/physiology , Physical Stimulation/methods , Pyrroles/pharmacology , Serotonin Receptor Agonists/pharmacology , TRPV Cation Channels/antagonists & inhibitors , Tissue Culture Techniques
11.
Cell Rep ; 21(11): 3102-3115, 2017 Dec 12.
Article in English | MEDLINE | ID: mdl-29241539

ABSTRACT

Mechanical and thermal hyperalgesia (pain hypersensitivity) are cardinal signs of inflammation. Although the mechanism underlying thermal hyperalgesia is well understood, the cellular and molecular basis of mechanical hyperalgesia is poorly described. Here, we have identified a subset of peptidergic C-fiber nociceptors that are insensitive to noxious mechanical stimuli under normal conditions but become sensitized to such stimuli when exposed to the inflammatory mediator nerve growth factor (NGF). Strikingly, NGF did not affect mechanosensitivity of other nociceptors. We show that these mechanoinsensitive "silent" nociceptors are characterized by the expression of the nicotinic acetylcholine receptor subunit alpha-3 (CHRNA3) and that the mechanically gated ion channel PIEZO2 mediates NGF-induced mechanosensitivity in these neurons. Retrograde tracing revealed that CHRNA3+ nociceptors account for ∼50% of all peptidergic nociceptive afferents innervating visceral organs and deep somatic tissues. Hence, our data suggest that NGF-induced "un-silencing" of CHRNA3+ nociceptors significantly contributes to the development of mechanical hyperalgesia during inflammation.


Subject(s)
Hyperalgesia/genetics , Ion Channels/genetics , Mechanotransduction, Cellular , Nerve Growth Factor/pharmacology , Nociceptors/drug effects , Receptors, Nicotinic/genetics , Animals , Biomechanical Phenomena , Evoked Potentials, Somatosensory/drug effects , Evoked Potentials, Somatosensory/physiology , Ganglia, Spinal/cytology , Ganglia, Spinal/drug effects , Ganglia, Spinal/metabolism , Gene Expression Regulation , Hyperalgesia/metabolism , Hyperalgesia/physiopathology , Ion Channels/metabolism , Mice , Mice, Transgenic , Nociceptors/cytology , Nociceptors/metabolism , Pain/genetics , Pain/metabolism , Pain/physiopathology , Patch-Clamp Techniques , Primary Cell Culture , Receptors, Nicotinic/metabolism
12.
J Physiol ; 595(8): 2661-2679, 2017 04 15.
Article in English | MEDLINE | ID: mdl-28105664

ABSTRACT

KEY POINTS: Voltage-gated sodium channels play a fundamental role in determining neuronal excitability. Specifically, voltage-gated sodium channel subtype NaV 1.7 is required for sensing acute and inflammatory somatic pain in mice and humans but its significance in pain originating from the viscera is unknown. Using comparative behavioural models evoking somatic and visceral pain pathways, we identify the requirement for NaV 1.7 in regulating somatic (noxious heat pain threshold) but not in visceral pain signalling. These results enable us to better understand the mechanisms underlying the transduction of noxious stimuli from the viscera, suggest that the investigation of pain pathways should be undertaken in a modality-specific manner and help to direct drug discovery efforts towards novel visceral analgesics. ABSTRACT: Voltage-gated sodium channel NaV 1.7 is required for acute and inflammatory pain in mice and humans but its significance for visceral pain is unknown. Here we examine the role of NaV 1.7 in visceral pain processing and the development of referred hyperalgesia using a conditional nociceptor-specific NaV 1.7 knockout mouse (NaV 1.7Nav1.8 ) and selective small-molecule NaV 1.7 antagonist PF-5198007. NaV 1.7Nav1.8 mice showed normal nociceptive behaviours in response to intracolonic application of either capsaicin or mustard oil, stimuli known to evoke sustained nociceptor activity and sensitization following tissue damage, respectively. Normal responses following induction of cystitis by cyclophosphamide were also observed in both NaV 1.7Nav1.8 and littermate controls. Loss, or blockade, of NaV 1.7 did not affect afferent responses to noxious mechanical and chemical stimuli in nerve-gut preparations in mouse, or following antagonism of NaV 1.7 in resected human appendix stimulated by noxious distending pressures. However, expression analysis of voltage-gated sodium channel α subunits revealed NaV 1.7 mRNA transcripts in nearly all retrogradely labelled colonic neurons, suggesting redundancy in function. By contrast, using comparative somatic behavioural models we identify that genetic deletion of NaV 1.7 (in NaV 1.8-expressing neurons) regulates noxious heat pain threshold and that this can be recapitulated by the selective NaV 1.7 antagonist PF-5198007. Our data demonstrate that NaV 1.7 (in NaV 1.8-expressing neurons) contributes to defined pain pathways in a modality-dependent manner, modulating somatic noxious heat pain, but is not required for visceral pain processing, and advocate that pharmacological block of NaV 1.7 alone in the viscera may be insufficient in targeting chronic visceral pain.


Subject(s)
NAV1.7 Voltage-Gated Sodium Channel/deficiency , Nociceptors/metabolism , Visceral Pain/metabolism , Adult , Aged , Aged, 80 and over , Animals , Capsaicin/toxicity , Female , Humans , Male , Mice , Mice, Knockout , Mustard Plant/toxicity , NAV1.7 Voltage-Gated Sodium Channel/genetics , Nociceptive Pain/chemically induced , Nociceptive Pain/genetics , Nociceptive Pain/metabolism , Nociceptors/drug effects , Plant Oils/toxicity , Signal Transduction/drug effects , Signal Transduction/physiology , Sodium Channel Blockers/pharmacology , Visceral Pain/chemically induced , Visceral Pain/genetics
13.
Pain ; 157(11): 2571-2581, 2016 11.
Article in English | MEDLINE | ID: mdl-27454463

ABSTRACT

Dysmenorrhea is a common chronic pelvic pain syndrome affecting women of childbearing potential. Family studies suggest that genetic background influences the severity of dysmenorrhea, but genetic predisposition and molecular mechanisms underlying dysmenorrhea are not understood. In this study, we conduct the first genome-wide association study to identify genetic factors associated with dysmenorrhea pain severity. A cohort of females of European descent (n = 11,891) aged 18 to 45 years rated their average dysmenorrhea pain severity. We used a linear regression model adjusting for age and body mass index, identifying one genome-wide significant (P < 5 × 10) association (rs7523086, P = 4.1 × 10, effect size 0.1 [95% confidence interval, 0.074-0.126]). This single nucleotide polymorphism is colocalising with NGF, encoding nerve growth factor. The presence of one risk allele corresponds to a predicted 0.1-point increase in pain intensity on a 4-point ordinal pain scale. The putative effects on NGF function and/or expression remain unknown. However, genetic variation colocalises with active epigenetic marks in fat and ovary tissues, and expression levels in aorta tissue of a noncoding RNA flanking NGF correlate. Participants reporting extreme dysmenorrhea pain were more likely to report being positive for endometriosis, polycystic ovarian syndrome, depression, and other psychiatric disorders. Our results indicate that dysmenorrhea pain severity is partly genetically determined. NGF already has an established role in chronic pain disorders, and our findings suggest that NGF may be an important mediator for gynaecological/pelvic pain in the viscera.


Subject(s)
Chromosomes, Human, Pair 1/genetics , Dysmenorrhea/genetics , Nerve Growth Factor/genetics , Polymorphism, Single Nucleotide/genetics , Adolescent , Adult , Age Factors , Cohort Studies , Female , Genome-Wide Association Study , Humans , Middle Aged , Nerve Growth Factor/metabolism , Pain Measurement , Young Adult
14.
J Neurosci ; 36(8): 2364-76, 2016 Feb 24.
Article in English | MEDLINE | ID: mdl-26911685

ABSTRACT

Activation of visceral nociceptors by inflammatory mediators contributes to visceral hypersensitivity and abdominal pain associated with many gastrointestinal disorders. Purine and pyrimidine nucleotides (e.g., ATP and UTP) are strongly implicated in this process following their release from epithelial cells during mechanical stimulation of the gut, and from immune cells during inflammation. Actions of ATP are mediated through both ionotropic P2X receptors and metabotropic P2Y receptors. P2X receptor activation causes excitation of visceral afferents; however, the impact of P2Y receptor activation on visceral afferents innervating the gut is unclear. Here we investigate the effects of stimulating P2Y receptors in isolated mouse colonic sensory neurons, and visceral nociceptor fibers in mouse and human nerve-gut preparations. Additionally, we investigate the role of Nav1.9 in mediating murine responses. The application of UTP (P2Y2 and P2Y4 agonist) sensitized colonic sensory neurons by increasing action potential firing to current injection and depolarizing the membrane potential. The application of ADP (P2Y1, P2Y12, and P2Y13 agonist) also increased action potential firing, an effect blocked by the selective P2Y1 receptor antagonist MRS2500. UTP or ADP stimulated afferents, including mouse and human visceral nociceptors, in nerve-gut preparations. P2Y1 and P2Y2 transcripts were detected in 80% and 56% of retrogradely labeled colonic neurons, respectively. Nav1.9 transcripts colocalized in 86% of P2Y1-positive and 100% of P2Y2-positive colonic neurons, consistent with reduced afferent fiber responses to UTP and ADP in Na(v)1.9(-/-) mice. These data demonstrate that P2Y receptor activation stimulates mouse and human visceral nociceptors, highlighting P2Y-dependent mechanisms in the generation of visceral pain during gastrointestinal disease.


Subject(s)
Colon/metabolism , Nociceptors/metabolism , Receptors, Purinergic P2Y/biosynthesis , Adolescent , Adult , Aged , Aged, 80 and over , Animals , Cells, Cultured , Colon/drug effects , Female , Ganglia, Spinal/drug effects , Ganglia, Spinal/metabolism , Humans , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Middle Aged , NAV1.9 Voltage-Gated Sodium Channel/physiology , Purine Nucleotides/pharmacology , Pyrimidine Nucleotides/pharmacology , Species Specificity
15.
Pain ; 155(10): 1962-75, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24972070

ABSTRACT

Chronic visceral pain affects millions of individuals worldwide and remains poorly understood, with current therapeutic options constrained by gastrointestinal adverse effects. Visceral pain is strongly associated with inflammation and distension of the gut. Here we report that the voltage-gated sodium channel subtype NaV1.9 is expressed in half of gut-projecting rodent dorsal root ganglia sensory neurons. We show that NaV1.9 is required for normal mechanosensation, for direct excitation and for sensitization of mouse colonic afferents by mediators from inflammatory bowel disease tissues, and by noxious inflammatory mediators individually. Excitatory responses to ATP or PGE2 were substantially reduced in NaV1.9(-/-) mice. Deletion of NaV1.9 substantially attenuates excitation and subsequent mechanical hypersensitivity after application of inflammatory soup (IS) (bradykinin, ATP, histamine, PGE2, and 5HT) to visceral nociceptors located in the serosa and mesentery. Responses to mechanical stimulation of mesenteric afferents were also reduced by loss of NaV1.9, and there was a rightward shift in stimulus-response function to ramp colonic distension. By contrast, responses to rapid, high-intensity phasic distension of the colon are initially unaffected; however, run-down of responses to repeat phasic distension were exacerbated in NaV1.9(-/-) afferents. Finally colonic afferent activation by supernatants derived from inflamed human tissue was greatly reduced in NaV1.9(-/-) mice. These results demonstrate that NaV1.9 is required for persistence of responses to intense mechanical stimulation, contributes to inflammatory mechanical hypersensitivity, and is essential for activation by noxious inflammatory mediators, including those from diseased human bowel. These observations indicate that NaV1.9 represents a high-value target for development of visceral analgesics.


Subject(s)
Colon/innervation , Hyperalgesia/metabolism , NAV1.9 Voltage-Gated Sodium Channel/metabolism , Visceral Afferents/metabolism , Action Potentials/drug effects , Adenosine Triphosphate/pharmacology , Adolescent , Adult , Aged , Animals , Colon/metabolism , Colon/physiopathology , Dinoprostone/pharmacology , Female , Ganglia, Spinal/drug effects , Ganglia, Spinal/metabolism , Ganglia, Spinal/physiopathology , Humans , Hyperalgesia/physiopathology , Inflammation/metabolism , Inflammation/physiopathology , Inflammatory Bowel Diseases/metabolism , Inflammatory Bowel Diseases/physiopathology , Male , Mice , Mice, Knockout , Middle Aged , NAV1.9 Voltage-Gated Sodium Channel/genetics , Physical Stimulation , Visceral Afferents/drug effects , Visceral Afferents/physiopathology , Young Adult
16.
Cell Transplant ; 22(6): 1041-51, 2013.
Article in English | MEDLINE | ID: mdl-23007077

ABSTRACT

Islet autotransplant patients represent excellent subjects to assess the posttransplant impact of islet precursors, as chronic pancreatitis (CP) causes an elevation of ductal cells, pancreatic precursors cells, and hormone-positive acinar cells. The relationship between these cell types and autograft outcomes should be more apparent than would be the case in the context of an allograft program with confounding immunological variables. To improve diabetic control following total pancreatectomy for CP, nonpurified islets were autotransplanted into the liver. Pancreas specimens were recovered from 23 patients and stained for antigens including: insulin, glucagon, cytokeratin 19, cytokeratin 7, and PDX-1. In line with previous reports, the prevalence of ductal cells, non-islet endocrine cells and non-islet PDX-1-expressing cells was significantly higher in CP glands compared with normal pancreata. When correlating follow-up data (i.e., fasting and stimulated C-peptide/glucose levels and HbA1c%) with pancreas immunoreactivity, high levels of ductal cells, non-islet PDX-1-positive cells, and non-islet glucagon-positive cells were associated with superior outcomes, detectable up to 2 years posttransplant. To conclude, the acinar parenchyma and ductal epithelium of the CP pancreas show an upregulation of both endocrine and pre-endocrine cell types, which appear to have a positive effect on islet graft outcomes in autotransplantation setting.


Subject(s)
Islets of Langerhans Transplantation , Islets of Langerhans/cytology , Stem Cells/cytology , Biomarkers/metabolism , Epithelial Cells/metabolism , Epithelial Cells/pathology , Glucagon/metabolism , Homeodomain Proteins/metabolism , Humans , Insulin/metabolism , Keratins/metabolism , Pancreatic Ducts/metabolism , Pancreatic Ducts/pathology , Pancreatitis, Chronic/metabolism , Pancreatitis, Chronic/pathology , Trans-Activators/metabolism , Transplantation, Autologous
17.
Environ Toxicol Chem ; 30(1): 239-46, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20872898

ABSTRACT

Toxicity tests using nine freshwater species (Ceriodaphnia dubia, Daphnia magna, Oncorhynchus mykiss, Pimephales promelas, Lumbriculus variegatus, Tubifex tubifex, Chironomus dilutus, Hyallela azteca, and Brachionus calyciflorus) were conducted to evaluate their sensitivity to chloride. Acute-to-chronic ratios (ACRs) from these tests indicate the ACR of 7.59 employed by the United States Environmental Protection Agency (U.S. EPA) in deriving its water quality guideline for chloride may be conservative; a revised ACR of 3.50 is presented here. The endpoints used to calculate the ACR included 24-h to 96-h median lethal concentrations (LC50s) for acute tests, and 48-h to 54-d inhibition concentration (ICx) values for growth or reproduction for chronic exposures. Data from the present chronic toxicity tests, and other investigators, were used to propose a water quality guideline for long-term exposure to chloride using a species sensitivity distribution (SSD) approach. The 5th percentile from the SSD was calculated as 307 mg/L and proposed as the water quality guideline. Cladocerans were the most sensitive species in the dataset. Ceriodaphnia dubia was used to evaluate the relationship between water hardness and sensitivity to chloride. A strong relationship was observed and was used to establish a hardness-related equation to modify the proposed water quality guideline on the basis of water hardness, resulting in values ranging from 64 mg/L chloride at 10 mg/L hardness to 388 mg/L chloride at 160 mg/L hardness (as CaCO3). These data suggest that current water quality guidelines for chloride may be overly conservative in water with moderate-to-high hardness, and may not be sufficiently protective under soft-water conditions.


Subject(s)
Aquatic Organisms/drug effects , Chlorides/toxicity , Fresh Water/chemistry , Water Pollutants, Chemical/toxicity , Amphipoda/drug effects , Animals , Chironomidae/drug effects , Chlorides/analysis , Chlorides/standards , Cyprinidae , Daphnia/drug effects , Dose-Response Relationship, Drug , Environmental Policy , Oligochaeta/drug effects , Oncorhynchus mykiss , Risk Assessment , Rotifera/drug effects , Toxicity Tests, Acute , Toxicity Tests, Chronic , United States , United States Environmental Protection Agency , Water Pollutants, Chemical/analysis , Water Pollutants, Chemical/standards , Water Pollution/legislation & jurisprudence
18.
Environ Toxicol Chem ; 29(12): 2800-5, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20891017

ABSTRACT

Gametes were collected from Dolly Varden char (Salvelinus malma) from waterbodies in a region exposed to mining-related selenium (Se) releases in British Columbia, Canada. Fertilized eggs were incubated in a laboratory and deformities were assessed on newly-hatched alevins using a graduated severity index. No effects were observed on egg or alevin survival or larval weight across the studied exposure range of 5.4 to 66 mg/kg dry weight in egg. Length of some larvae was reduced at the highest egg Se concentrations and a clear residue-response relationship was observed for larval deformity. The egg concentration corresponding to a 10% increase in the frequency of deformity (EC10) was 54 mg/kg dry weight, which is substantially higher than reported for other cold-water fish species.


Subject(s)
Oncorhynchus/abnormalities , Selenium/poisoning , Water Pollutants, Chemical/poisoning , Animals , British Columbia , Female , Mining , Oncorhynchus/embryology , Reproduction/drug effects , Selenium/analysis , Toxicity Tests/methods , Water Pollutants, Chemical/analysis
19.
Clin Exp Immunol ; 159(1): 23-44, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19912253

ABSTRACT

Type 1 diabetes (T1D) is caused by the selective destruction of the insulin-producing beta cells of the pancreas by an autoimmune response. Due to ethical and practical difficulties, the features of the destructive process are known from a small number of observations, and transcriptomic data are remarkably missing. Here we report whole genome transcript analysis validated by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and correlated with immunohistological observations for four T1D pancreases (collected 5 days, 9 months, 8 and 10 years after diagnosis) and for purified islets from two of them. Collectively, the expression profile of immune response and inflammatory genes confirmed the current views on the immunopathogenesis of diabetes and showed similarities with other autoimmune diseases; for example, an interferon signature was detected. The data also supported the concept that the autoimmune process is maintained and balanced partially by regeneration and regulatory pathway activation, e.g. non-classical class I human leucocyte antigen and leucocyte immunoglobulin-like receptor, subfamily B1 (LILRB1). Changes in gene expression in islets were confined mainly to endocrine and neural genes, some of which are T1D autoantigens. By contrast, these islets showed only a few overexpressed immune system genes, among which bioinformatic analysis pointed to chemokine (C-C motif) receptor 5 (CCR5) and chemokine (CXC motif) receptor 4) (CXCR4) chemokine pathway activation. Remarkably, the expression of genes of innate immunity, complement, chemokines, immunoglobulin and regeneration genes was maintained or even increased in the long-standing cases. Transcriptomic data favour the view that T1D is caused by a chronic inflammatory process with a strong participation of innate immunity that progresses in spite of the regulatory and regenerative mechanisms.


Subject(s)
Diabetes Mellitus, Type 1/metabolism , Diabetes Mellitus, Type 1/pathology , Gene Expression Profiling , Islets of Langerhans/metabolism , Pancreas/metabolism , Pancreas/pathology , Adolescent , Adult , Antigens, CD/analysis , Antigens, CD/genetics , Antigens, CD/metabolism , Antigens, Neoplasm/genetics , Antigens, Neoplasm/metabolism , Biomarkers, Tumor/genetics , Biomarkers, Tumor/metabolism , C-Reactive Protein/genetics , C-Reactive Protein/metabolism , Cell Count , Diabetes Mellitus, Type 1/immunology , Down-Regulation/genetics , Female , Gene Expression/genetics , Glucagon-Secreting Cells/metabolism , HLA Antigens/genetics , HLA Antigens/metabolism , Histocompatibility Antigens Class I/genetics , Histocompatibility Antigens Class I/metabolism , Humans , Immunity, Innate/genetics , Inflammation/genetics , Insulin-Secreting Cells/metabolism , Islets of Langerhans/pathology , Lectins, C-Type/genetics , Lectins, C-Type/metabolism , Leukocytes/metabolism , Male , Middle Aged , Pancreatitis-Associated Proteins , Reverse Transcriptase Polymerase Chain Reaction , Up-Regulation/genetics , Young Adult , HLA-E Antigens
20.
J Immunol Methods ; 306(1-2): 202-10, 2005 Nov 30.
Article in English | MEDLINE | ID: mdl-16225888

ABSTRACT

We report the production and characterisation of three monoclonal antibodies to the prion protein (PrP) of Rainbow trout (Oncorhynchus mykiss), a piscine protein with characteristic structural features common to mammalian prion protein. All of the antibodies were used to detect PrP in ELISA, Western blot and by immunohistochemistry. The antibodies showed specificity for certain genera of the Salmonidae, binding to PrP of Rainbow trout and Atlantic salmon (Salmo salar) but not to that from Arctic char (Salvelinus alpinus). Using the immunoreagents in Western blots, we demonstrated that O. mykiss PrP protein is a 64 kDa protein present in brain, spinal chord and optic nerve. PrP was not detected in a range of peripheral tissues: eye, heart, stomach, intestine, liver, kidney, spleen, muscle and skin. Furthermore, PrP could be detected in all brain regions studied: optic lobe, cerebrum/olfactory lobe, cerebellum, hypothalamus/pituitary and medulla oblongata and was widespread within these tissues as determined by immunohistochemistry. These immunoreagents provide specific tools to study the biology of Rainbow trout and Atlantic salmon PrP and any possible transmissible spongiform encephalopathy-like disease of these economically important fish species.


Subject(s)
Antibodies, Monoclonal/biosynthesis , Antibodies, Monoclonal/immunology , Oncorhynchus mykiss/immunology , Prions/immunology , Amino Acid Sequence , Animals , Antibody Specificity , Epitope Mapping , Molecular Sequence Data , Prions/analysis , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...